Early and late outcome after elective cardiac surgery in patients with cirrhosis

被引:90
作者
Bizouarn, P [1 ]
Ausseur, A
Desseigne, P
Le Teurnier, Y
Nougarede, B
Train, M
Michaud, JL
机构
[1] Hop Laennec, Serv Anesthesie Reanimat, Dept Anesthesiol, F-44035 Nantes, France
[2] Hop Laennec, Dept Cardiothorac Surg, F-44035 Nantes, France
关键词
D O I
10.1016/S0003-4975(99)00226-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. A prospective study was performed to evaluate the early and late outcome after elective cardiac surgery in patients with cirrhosis. Methods. All patients who underwent elective cardiac surgery between 1995 and 1997, and were suspected of having a history of cirrhosis, were followed in the intensive care unit (ICU), during hospitalization and after hospital discharge. All patients received high doses of aprotinin during surgery. Results. Ten patients of Child-Pugh class A and 2 patients of Child-Pugh class B were studied. All patients had signs of portal hypertension, and 11 of 12 patients had thrombocytopenia. In the first 24 h after operation, the median chest tube output was 810 mL (range 350 to 1,500 mL). Median ICU and hospital stays were 3 and 15 days, respectively (range 2 to 10 and 7 to 36 days, respectively). Seven patients experienced postoperative morbidity and 7 patients had significant complications after their hospital discharge. One death occurred in the ICU. Two deaths occurred after hospital discharge and were related to further hepatic damage. Conclusions. These results suggest that, in patients with mild or moderate cirrhosis, the incidence of significant complications was high after elective cardiac surgery, increasing the length of stay in ICU and overall hospitalization time and compromising the health status, even well after the operation. (Ann Thorac Surg 1999;67:1334-8) (C) 1999 by The Society of Thoracic Surgeons.
引用
收藏
页码:1334 / 1338
页数:5
相关论文
共 15 条
  • [1] AZOULAY D, 1994, HEPATOLOGY, V19, P129, DOI 10.1002/hep.1840190121
  • [2] DESAI J B, 1990, Perfusion (London), V5, P161, DOI 10.1177/026765919000500302
  • [3] THE USE OF HIGH-DOSE APROTININ IN LIVER-TRANSPLANTATION - THE INFLUENCE ON FIBRINOLYSIS AND BLOOD-LOSS
    GROSSE, H
    LOBBES, W
    FRAMBACH, M
    VONBROEN, O
    RINGE, B
    BARTHELS, M
    [J]. THROMBOSIS RESEARCH, 1991, 63 (03) : 287 - 297
  • [4] TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT STENOSIS AND REVISION - EARLY AND MIDTERM RESULTS
    HASKAL, ZJ
    PENTECOST, MJ
    SOULEN, MC
    SHLANSKYGOLDBERG, RD
    BAUM, RA
    COPE, C
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 1994, 163 (02) : 439 - 444
  • [5] Cardiac operations in patients with cirrhosis
    Klemperer, JD
    Ko, W
    Krieger, KH
    Connolly, M
    Rosengart, TK
    Altorki, NK
    Lang, S
    Isom, OW
    [J]. ANNALS OF THORACIC SURGERY, 1998, 65 (01) : 85 - 87
  • [6] CREATION OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNTS WITH THE WALLSTENT ENDOPROSTHESIS - RESULTS IN 100 PATIENTS
    LABERGE, JM
    RING, EJ
    GORDON, RL
    LAKE, JR
    DOHERTY, MM
    SOMBERG, KA
    ROBERTS, JP
    ASCHER, NL
    [J]. RADIOLOGY, 1993, 187 (02) : 413 - 420
  • [7] Drugs to minimize perioperative blood loss in cardiac surgery: Meta-analyses using perioperative blood transfusion as the outcome
    Laupacis, A
    Fergusson, D
    [J]. ANESTHESIA AND ANALGESIA, 1997, 85 (06) : 1258 - 1267
  • [8] Continuous small-dose aprotinin controls fibrinolysis during orthotopic liver transplantation
    Marcel, RJ
    Stegall, WC
    Suit, CT
    Arnold, JC
    Vera, RL
    Ramsay, MAE
    ODonnell, MB
    Swygert, TH
    Hein, HAT
    Whitten, CW
    [J]. ANESTHESIA AND ANALGESIA, 1996, 82 (06) : 1122 - 1125
  • [9] MATHIE RT, 1993, CRIT CARE MED S2, V21, P72
  • [10] Michalopoulos A, 1997, HEPATO-GASTROENTEROL, V44, P779